Business · 19/05/2025
FDA to Host Public Meeting on Reauthorization of Prescription Drug User Fee Act
The FDA is hosting a public meeting to gather public input on proposed recommendations for reauthorizing the Prescription Drug User Fee Act for fiscal years 2028 through 2032, with comments to be published on the FDA website.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →